Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1979 Aug;32(8):814–821. doi: 10.1136/jcp.32.8.814

Platelet function in hairy-cell leukaemia

M Zuzel 1, J C Cawley 1, R C Paton 1, G F Burns 2, G P McNicol 1
PMCID: PMC1145815  PMID: 512041

Abstract

A quantitative study of various aspects of platelet function was carried out in eight patients with typical hairy-cell leukaemia (HCL). In at least two patients platelet aggregation was convincingly reduced to more than one aggregating agent (ADP, adrenaline, collagen, thrombin, and ristocetin). Granular storage capacity for {14C} 5-HT was reduced in five of the six patients tested. The two patients with definitely abnormal aggregation had the greatest reduction in granular storage pool and the longest bleeding times of those tested but, like the other patients, they did not have a clinical haemostatic defect. It was concluded that a granular storage pool defect (SPD) was at least partly responsible for aggregation abnormalities in HCL since the platelet release reaction in response to thrombin appeared to be normal. All our patients ran a chronic course uncomplicated by any of the factors known to predispose to a platelet SPD acquired in the circulation. Although in the one patient tested before and after splenectomy there was some improvement in platelet aggregation after operation, there was no clear general relationship between defective platelet function and either previous splenectomy or platelet count. Since a direct involvement of the megakaryocytic series in the underlying cell proliferation of HCL seems unlikely, it is concluded that the platelet defect can most reasonably be attributed to the production of abnormal platelets as a result of marrow fibrosis and/or infiltration by hairy cells.

Full text

PDF
814

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASTER R. H., JANDL J. H. PLATELET SEQUESTRATION IN MAN. I. METHODS. J Clin Invest. 1964 May;43:843–855. doi: 10.1172/JCI104970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BOURONCLE B. A., WISEMAN B. K., DOAN C. A. Leukemic reticuloendotheliosis. Blood. 1958 Jul;13(7):609–630. [PubMed] [Google Scholar]
  3. BRECHER G., CRONKITE E. P. Morphology and enumeration of human blood platelets. J Appl Physiol. 1950 Dec;3(6):365–377. doi: 10.1152/jappl.1950.3.6.365. [DOI] [PubMed] [Google Scholar]
  4. Boullin D. J., O'Brien R. A. Abnormalities of 5-hydroxytryptamine uptake and binding by blood platelets from children with Down's syndrome. J Physiol. 1971 Jan;212(2):287–297. doi: 10.1113/jphysiol.1971.sp009325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Catovsky D. Hairy-cell leukaemia and prolymphocytic leukaemia. Clin Haematol. 1977 Feb;6(1):245–268. [PubMed] [Google Scholar]
  6. Costa J. L., Murphy D. L., Kafka M. S. Demonstration and evaluation of apparent cytoplasmic and vesicular serotonin compartments in human platelets. Biochem Pharmacol. 1977 Mar 15;26(6):517–521. doi: 10.1016/0006-2952(77)90327-6. [DOI] [PubMed] [Google Scholar]
  7. Cowan D. H., Graham R. C., Jr, Baunach D. The platelet defect in leukemia. Platelet ultrastructure, adenine nucleotide metabolism, and the release reaction. J Clin Invest. 1975 Jul;56(1):188–200. doi: 10.1172/JCI108067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Da Prada M., Pletscher A. Isolated 5-hydroxytryptamine organelles of rabbit blood platelets: physiological properties and drug-induced changes. Br J Pharmacol. 1968 Nov;34(3):591–597. doi: 10.1111/j.1476-5381.1968.tb08487.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Feiner A. S., Meyers A. M., Jr, Moore G. E. Leukemic reticuloendotheliosis. Loss of platelet defect after splenectomy. JAMA. 1978 Jul 21;240(3):238–240. doi: 10.1001/jama.240.3.238. [DOI] [PubMed] [Google Scholar]
  10. Gerrard J. M., Stoddard S. F., Shapiro R. S., Coccia P. F., Ramsay N. K., Nesbit M. E., Rao G. H., Krivit W., White J. G. Platelet storage pool deficiency and prostaglandin synthesis in chronic granulocytic leukaemia. Br J Haematol. 1978 Dec;40(4):597–607. doi: 10.1111/j.1365-2141.1978.tb05836.x. [DOI] [PubMed] [Google Scholar]
  11. Golde D. W., Stevens R. H., Quan S. G., Saxon A. Immunoglobulin synthesis in hairy cell leukaemia. Br J Haematol. 1977 Mar;35(3):359–365. doi: 10.1111/j.1365-2141.1977.tb00595.x. [DOI] [PubMed] [Google Scholar]
  12. Golomb H. M. Hairy cell leukemia: an unusual lymphoproliferative disease: a study of 24 patients. Cancer. 1978 Aug;42(2 Suppl):946–956. doi: 10.1002/1097-0142(197808)42:2+<946::aid-cncr2820420718>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  13. Golomb H. M., Vardiman J., Sweet D. L., Jr, Simon D., Variakojis D. Hairy cell leukaemia: evidence for the existence of a spectrum of functional characteristics. Br J Haematol. 1978 Feb;38(2):161–170. doi: 10.1111/j.1365-2141.1978.tb01032.x. [DOI] [PubMed] [Google Scholar]
  14. HARDISTY R. M., STACEY R. S. Platelet 5-hydroxytryptamine (HT) in disorders of the blood. Br J Haematol. 1957 Jul;3(3):292–298. doi: 10.1111/j.1365-2141.1957.tb05799.x. [DOI] [PubMed] [Google Scholar]
  15. Hardisty R. M., Mills D. C., Ketsa-Ard K. The platelet defect associated with albumism. Br J Haematol. 1972 Dec;23(6):679–692. doi: 10.1111/j.1365-2141.1972.tb03483.x. [DOI] [PubMed] [Google Scholar]
  16. Harker L. A., Slichter S. J. Platelet and fibrinogen consumption in man. N Engl J Med. 1972 Nov 16;287(20):999–1005. doi: 10.1056/NEJM197211162872001. [DOI] [PubMed] [Google Scholar]
  17. Hess H. H., Lees M. B., Derr J. E. A linear Lowry--Folin assay for both water-soluble and sodium dodecyl sulfate-solubilized proteins. Anal Biochem. 1978 Mar;85(1):295–300. doi: 10.1016/0003-2697(78)90304-4. [DOI] [PubMed] [Google Scholar]
  18. Jansen J., Hermans J., Remme J., den Ottolander G. J., Cardozo P. L. Hairy cell leukaemia. Clinical features and effect of splenectomy. Scand J Haematol. 1978 Jul;21(1):60–71. [PubMed] [Google Scholar]
  19. Katayama I., Finkel H. E. Leukemic reticuloendotheliosis. A clinicopathologic study with review of the literature. Am J Med. 1974 Jul;57(1):115–126. doi: 10.1016/0002-9343(74)90776-1. [DOI] [PubMed] [Google Scholar]
  20. Levine P. H., Katayama I. The platelet in leukemic reticuloendotheliosis. Functional and morphological evidence of a qualitative disorder. Cancer. 1975 Oct;36(4):1353–1358. doi: 10.1002/1097-0142(197510)36:4<1353::aid-cncr2820360425>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  21. Lewis S. M., Catovsky D., Hows J. M., Ardalan B. Splenic red cell pooling in hairy cell leukaemia. Br J Haematol. 1977 Mar;35(3):351–357. doi: 10.1111/j.1365-2141.1977.tb00594.x. [DOI] [PubMed] [Google Scholar]
  22. Mielke C. H., Jr, Kaneshiro M. M., Maher I. A., Weiner J. M., Rapaport S. I. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood. 1969 Aug;34(2):204–215. [PubMed] [Google Scholar]
  23. Pareti F. I., Capitanio A., Mannucci P. M. Acquired storage pool disease in platelets during disseminated intravascular coagulation. Blood. 1976 Oct;48(4):511–515. [PubMed] [Google Scholar]
  24. Pletscher A., Da Prada M., Tranzer J. P. Metabolism, subcellular transport and storage of 5-hydroxytryptamine in blood platelets. Ann Med Exp Biol Fenn. 1968;46(3):399–406. [PubMed] [Google Scholar]
  25. Reimers H. J., Allen D. J., Cazenave J. P., Feuerstein I. A., Mustard J. F. Serotonin transport and storage in rabbit blood platelets--the effects of reserpine and imipramine. Biochem Pharmacol. 1977 Sep 15;26(18):1645–1655. doi: 10.1016/0006-2952(77)90141-1. [DOI] [PubMed] [Google Scholar]
  26. Skoza L., Zucker M. B., Jerushalmy Z., Grant R. Kinetic studies of platelet aggregation induced by adenosine diphosphate and its inhibition by chelating agents, guanidino compounds, and adenosine. Thromb Diath Haemorrh. 1967 Dec 31;18(3-4):713–725. [PubMed] [Google Scholar]
  27. Tuomisto J. A new modification for studying 5-HT uptake by blood platelets: a re-evaluation of tricyclic antidepressants as uptake inhibitors. J Pharm Pharmacol. 1974 Feb;26(2):92–100. doi: 10.1111/j.2042-7158.1974.tb09231.x. [DOI] [PubMed] [Google Scholar]
  28. Weiss H. J., Tschopp T. B., Rogers J., Brand H. Studies of platelet 5-hydroxytryptamine (serotonin) in storage pool disease and albinism. J Clin Invest. 1974 Aug;54(2):421–433. doi: 10.1172/JCI107778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Zahavi J., Marder V. J. Acquired "storage pool disease" of platelets associated with circulating antiplatelet antibodies. Am J Med. 1974 Jun;56(6):883–890. doi: 10.1016/0002-9343(74)90819-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES